GlassScriptPhysician profile
Nooreen A Baig
NPI 1619387057
$6,756.82
in general payments reported to CMS, 2019-2025
52 companies · $1,845 in 2025
The $1,845 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $561 · 2022: $1,214 · 2023: $1,404 · 2024: $1,733 · 2025: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,981.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,114.31 | 2021-2025 | Qulipta, Linzess, Viberzi |
| Novo Nordisk INC | $664.64 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $518.85 | 2022-2025 | |
| Glaxosmithkline, LLC. | $432.94 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $384.89 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $349.99 | 2021-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $310.11 | 2021-2025 | |
| Radius Health, INC. | $272.66 | 2022-2025 | Tymlos |
| Dexcom, INC. | $214.82 | 2021-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $178.02 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $175.04 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.47 | 2022-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $141.11 | 2024-2025 | |
| Ibsa Pharma INC. | $140.91 | 2022-2025 | Tirosint, Licart, Flector |
| Ucb, INC. | $136.77 | 2022-2025 | Briviact, Nayzilam |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nooreen Baig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.